In vitro characterization of multidrug-resistant influenza A(H1N1)pdm09 viruses carrying a 1 dual amino acid substitution associated with reduced susceptibility to neuraminidase 2 
Abstract 23
We detected influenza A(H1N1)pdm09 viruses carrying dual H275Y/I223R, H275Y/I223K, 24 or H275Y/G147R substitutions in their neuraminidase protein, respectively. These viruses 25
showed cross-resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir. 26
The H275Y/G147R virus retained its replication capability at least in vitro, but the 27 H275Y/I223R and H275Y/I223K viruses did not. corresponding single H275Y viruses (Figures 2A and 2B) to that of wild-type viruses 89 decreased significantly. However, the proportion of the single H275Y virus corresponding to 90 the H275Y/G147R virus was comparable to that of wild-type virus ( Figure 2C ). Furthermore, 91 the H275Y/G147R virus rapidly became dominant in the mixed virus populations at passages 92 1 and 2 ( Figure 2F ). These results indicate that the H275Y/G147R virus retained comparable 93 growth ability to that of the wild-type virus, at least in vitro. 94
To assess the potential effect of the amino acid substitutions on the stability of the NA, we 95 performed an in silico mutagenesis study as previously described (11). The changes in 96 stability caused by each of the substitutions I223R, I223K, and G147R were 1.32, 3.29, and 97 -2.72 kcal/mol, respectively. The I223R and I223K substitutions were predicted to destabilise 98 the NA structure, whereas the G147R substitution was predicted to stabilise the NA, which 99 suggests that the G147R substitution compensates for structural disadvantages caused by the 100 H275Y substitution (12) . 101
102
The emergence of multidrug-resistant variants in patients treated with antiviral agents is a 103 concern. The dual H275Y/I223R, H275Y/I223K, and H275Y/G147R viruses exhibited 104 cross-resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir. The 105 patient who was infected with the H275Y/I223R virus recovered after laninamivir treatment; 106 however, the other two died despite treatment with oseltamivir, peramivir and/or laninamivir. 107
The dual H275Y mutant viruses were susceptible to favipiravir, suggesting that favipiravir 108 could be a treatment option against these multidrug-resistant viruses. 109
The NA enzymatic active site includes catalytic residues that interact directly with the sialic 110 acid substrate and framework residues that stabilize the active site (13). Residue 223 is 111 located within the framework, and different substitutions at this position have different 112 effects on NA inhibitor susceptibility (14). Residue 147 is located in a 150-loop, which are 113 adjacent to the NA active site (2, 3). The G147R substitution may alter the conformation of 114 the 150-loop due to the larger size and positive charge of the side chain, negatively affecting 115 the binding of NA inhibitors (2, 3). In this study, the NA activity of the H275Y/I223R and 116 H275Y/I223K viruses was significantly reduced, whereas the H275Y/G147R virus retained 117 its NA activity. These differences may be explained by the positions of amino acids, inside 118 or outside, the NA active site. 119
The single H275Y virus corresponding to the H275Y/G147R virus showed significantly 120 increased NA activity, but reduced growth capability compared to the wild-type virus. 121
However, the NA activity and growth capability of the H275Y/G147R virus was comparable 122 to that of the wild-type virus. An optimal balance between hemagglutinin (HA) receptor-123 binding and NA enzymatic activities is important for growth and transmissibility of influenza 124 viruses (15) (16) (17) . Mismatched HA and NA pairs can be rescued by amino acid substitutions 125 that compensate for increased or decreased activities (18). Thus, the introduction of the 126 G147R substitution into the H275Y mutant NA may compensate for the high NA activity, 127 resulting in the restoration of viral growth. 128
Our structural analysis predicts that the I223R and I223K substitutions destabilise the NA 129 structure, but the stability score for I223R was lower than that for I223K. These results 130
suggest that an NA with the I223R substitution is more stable than an NA with the I223K 131 substitution. 132
Hooper et al. reported that the G147R substitution confers receptor-binding activity to the 133 NA proteins and moderate resistance to neutralization by the Fab of a monoclonal antibody 134 against the HA receptor-binding pocket (19) . In this study, we showed that the 135 H275Y/G147R virus retained its replication capability at least in vitro. In fact, the patient 136 infected with the H275Y/G147R virus developed pneumonia without isolation of bacterial 137 pathogens, suggesting viral pneumonia with this dual mutant virus (3). 138
The multidrug-resistant viruses carrying the dual H275Y substitution were detected in 139 immunocompromised patients after prolonged treatment with one or more NA inhibitors. 140
Therefore, the emergence of resistant viruses during NA inhibitor administration should be 141 closely monitored to improve clinical management. Furthermore, the surveillance of 142 antiviral-resistant viruses should be continued to protect public health. 143
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